Search Results - "Renato, Daniela"

Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial by Martinelli, Erika, Martini, Giulia, Famiglietti, Vincenzo, Troiani, Teresa, Napolitano, Stefania, Pietrantonio, Filippo, Ciardiello, Davide, Terminiello, Marinella, Borrelli, Carola, Vitiello, Pietro Paolo, De Braud, Filippo, Morano, Federica, Avallone, Antonio, Normanno, Nicola, Nappi, Anna, Maiello, Evaristo, Latiano, Tiziana, Falcone, Alfredo, Cremolini, Chiara, Rossini, Daniele, Santabarbara, Giuseppe, Pinto, Carmine, Santini, Daniele, Cardone, Claudia, Zanaletti, Nicoletta, Di Liello, Alessandra, Renato, Daniela, Esposito, Lucia, Marrone, Francesca, Ciardiello, Fortunato

“…Rechallenge therapy with anti-epidermal growth factor receptor (EGFR) drugs has been suggested in patients with chemo-refractory RAS wild-type (WT) metastatic…”
Get more information

Final results from the CAVE (cetuximab rechallenge plus avelumab) mCRC phase II trial: Skin toxicity as a predictor of clinical activity by Martini, Giulia, Napolitano, Stefania, Famiglietti, Vincenzo, De Braud, Filippo G., Terminiello, Marinella, Borrelli, Carola, Vitiello, Pietro Paolo, Avallone, Antonio, Normanno, Nicola, Maiello, Evaristo, Falcone, Alfredo, Santabarbara, Giuseppe, Pinto, Carmine, Santini, Daniele, Di Liello, Alessandra, Renato, Daniela, Esposito, Lucia, Marrone, Francesca, Troiani, Teresa, Ciardiello, Davide

“…Abstract only 3578 Background: Promising antitumor activity of so called rechallenge treatment with anti-epidermal growth factor receptor (EGFR) drugs in…”
Get full text